Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: guarantee (67), certify (28), warrant (16)

Tisacel-Cytarabine (500)-Etoposide (150)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL – CYTARABINE (500) – ETOPOSI
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cytarabine-500-Etoposide-150.pdf

Tisacel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL– CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Regimen This regimen will only be av
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cyclophosphamide-500-Fludarabine-30-Ver1.pdf

InP-Cisplatin-Doxorubicin-Methotrexate (1-4)

Description: Chemotherapy Protocol Sarcoma CISPLATIN-DOXORUBICIN-METHOTREXATE (cycles 1-4) Inpatient Regimen There are multiple versions of this protocol in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Cisplatin-Doxorubicin-Methotrexate-1-4.pdf

Everolimus-Lenvatinib

Description: Chemotherapy Protocol RENAL CELL EVEROLIMUS and LENVATINIB Regimen • Renal Cell – Everolimus-Lenvatinib Indication • Confirmed histological
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Everolimus-Lenvatinib.pdf

ChlVPP-EVA-Chlorambucil-Doxorubicin-Etoposide-Prednisolone-Procarbazine-Vinblastine-Vincristine

Description: Chemotherapy Protocol LYMPHOMA CHLORAMBUCIL-DOXORUBICIN-ETOPOSIDE-PREDNISOLONE-PROCARBAZINEVINBLASTINE-VINCRISTINE (ChlVPP-EVA) Regimen • Lymphoma –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/ChlVPP-EVA-Chlorambucil-Doxorubicin-Etoposide-Prednisolone-Procarbazine-Vinblastine-Vincristine.pdf

HSCTCyclophosphamideTBI_Related_Methotrexate_GvHD

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)-METHOTREXATE (GvHD) Related Donor Conditioning This regimen will
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTCyclophosphamideTBI-Related-Methotrexate-GvHD.pdf

BRC-CRF patient and public engagement and participation strategy

Description: NIHR Southampton Biomedical Research Centre and Clinical Research Facility joint public engagement and participation strategy 2017-2022 Summ
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-CRF-patient-and-public-engagement-and-participation-strategy.pdf

Procedure for GEM 1 and 2 calorimeter

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system fo
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-GEM-1-and-2-calorimeter.pdf

B-AVD (Brentuximab vedotin-Dacarbazine-Doxorubicin-Vinblastine)

Description: Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (B- AVD) Regimen • Lymphoma –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/B-AVD-Brentuximab-vedotin-Dacarbazine-Doxorubicin-Vinblastine.pdf

Our outpatient vision 2025-2028 and 2025-2026 programme

Description: Our outpatient vision 2025 - 2028 UHS will deliver a new standardised outpatient service model, designed around the patient, ensuring that every
Url: /Media/UHS-website-2019/Docs/For-patients/UHS-outpatients-our-vision.pdf

271 to 280 of 1000

Previous … 26 27 28 29 30 … Next